Instruction for use: Euphyllin tablets 150 mg

Dosage form: tablets

Active substance: Aminophyllinum

ATX

R03DA05 Aminophylline

Pharmacological group

Adenosinergic agents

The nosological classification (ICD-10)

G46 Vascular cerebral syndromes in cerebrovascular diseases: Post-papoxic state; Chronic cerebrovascular insufficiency

G93.6 Brain edema: Intraoperative edema of the brain; Cerebral edema; Post-traumatic swelling of the brain; Brain edema associated with radiation therapy; Brain edema associated with head trauma; Post-traumatic cerebral edema; Edema of the brain in poisoning

I27 Other forms of cardiopulmonary diseases: Chronic pulmonary heart disease; Hypertension pulmonary circulation; Pulmonary hypertension; Pulmonary heart disease; pulmonary heart disease; Cardio-pulmonary insufficiency; Secondary pulmonary hypertension; Chronic pulmonary heart; Eisenmenger syndrome

I50.1 Left ventricular failure: Cardiac asthma; Asymptomatic dysfunction of the left ventricle; Asymptomatic left ventricular heart failure; Diastolic dysfunction of the left ventricle; Left ventricular dysfunction; Changes in the left ventricle with myocardial infarction; Left ventricular heart failure; Violation of the function of the left ventricle; Acute left ventricular failure; Acute cardiac left ventricular failure; Cardiac asthma; Heart failure of left ventricular; Changes in the lungs with left ventricular failure; Precordial abnormal pulsation; Lack of left ventricle

J45 Asthma: Asthma of physical effort; Asthmatic conditions; Bronchial asthma; Bronchial asthma of light course; Bronchial asthma with difficulty in sputum discharge; Bronchial asthma of severe course; Bronchial asthma physical effort; Hypersecretory asthma; The hormone-dependent form of bronchial asthma; Curbing asthma attacks with bronchial asthma; Non-allergic bronchial asthma; Night Asthma; Exacerbation of bronchial asthma; Attack of bronchial asthma; Endogenous forms of asthma; Night attacks of asthma; Cough with bronchial asthma

J98.8.0 * Bronchospasm: Bronchospasm with bronchial asthma; Bronchospasm when exposed to an allergen; Bronchospastic reactions; Bronchospastic conditions; Bronchospastic syndrome; Diseases accompanied by bronchospastic syndrome; Reversible bronchospasm; Spasmodic cough

N28.9 Kidney and ureter's disease, unspecified: Disturbance of ureter function; Autoimmune kidney damage; Kidney Diseases; Infringement of a renal blood flow; Impaired renal function; Impaired renal function; Nondiabetic nephropathy; Insufficiency of excretory function of the kidneys; Nephrogenic osteopathy; Nephropathic syndrome; Nephropathy of minimal changes; Maintaining kidney function; Chronic kidney disease; Megaloureter

Composition and release form

1 tablet contains aminophylline 0.15 g; In the bank 30 pcs. Or in bags of 8 kg.

Pharmachologic effect

Mode action - bronchodilating, diuretic, spasmolytic, vasodilating.

Indication for the Euphyllin tablets 150 mg

Bronchial asthma, bronchospastic syndrome, pulmonary hypertension, cardiac asthma; Chronic cerebral circulatory insufficiency, cerebral edema, impaired renal blood flow.

Contraindications

Myocardial infarction, pronounced coronary spasm, paroxysmal tachycardia, coronaro atherosclerosis.

Application of pregnancy and breastfeeding

It is not contraindicated.

Side effects

Dyspeptic disorders (nausea, vomiting, etc.), headache, dizziness, hypotension, palpitations, convulsions.

Interaction

Compatible with other antispasmodics.

Dosing and Administration

Inside, after eating - 0.1-0.2 g 2-3 times a day; Children - 7-10 mg / kg per day in 4 divided doses. Duration of treatment - up to several months.

Storage conditions of the drug Euphyllin tablets 150 mg

In the dry, dark place.

Keep out of the reach of children.

Shelf life of the drug Euphyllin tablets 150 mg

Tablets 150 mg -

Do not use after the expiry date printed on the package.